UAMY stock is trading at $10.30 in pre-market US trading ahead of an earnings release scheduled for Mar 19, 2026. Volume is elevated with 12,525,622 shares reported and a 50-day average near $8.65, showing momentum into the report. Investors will watch revenue mix, precious-metals offsets and guidance for antimony demand, since those items connect directly to valuation and short-term price action on the NYSE in the United States.
UAMY stock: pre-earnings snapshot
United States Antimony Corporation (UAMY) trades on the NYSE in USD at $10.30 after a recent intraday range of $10.19–$11.19. Market cap is about $1,198,737,679, shares outstanding are 116,269,416, and the company reports EPS of -0.04, giving a trailing PE that is negative and not meaningful for earnings comparatives. This snapshot frames why the upcoming earnings matter for both near-term trading and medium-term valuation.
What to watch in the UAMY earnings report
Key items for the Mar 19, 2026 release: production volumes for antimony oxide, prices realized on antimony and precious metals, and any commentary on zeolite sales. Management guidance and cost trends will influence margins; the company shows a gross margin near 25.78% and operating margin negative 17.53% last twelve months. Expect analysts to focus on cash flow lines because free cash flow per share is negative -0.17.
Analyst consensus, price targets and valuation
Wall Street coverage skews bullish with five analysts at Buy and an average price target of $8.75, though recent broker notes range up to $11.00. Valuation ratios look rich on current price: price-to-sales is about 36.62, price-to-book near 17.93, and enterprise value multiples are elevated. For source context, see MarketBeat coverage and the MarketWatch data summary source and source.
Technicals, liquidity and trading context for UAMY stock
Momentum indicators show a short-term uptrend: RSI 58.56, MACD histogram 0.17, and ADX 35.90 indicating a strong trend. Average volume sits at 14,342,784 shares but recent sessions saw 12,525,622, so liquidity is available but can amplify moves around the report. Bollinger upper band is 11.13, which gives a technical resistance band to watch if earnings beat expectations.
Meyka AI grade, forecast and model output
Meyka AI rates UAMY with a score of 69.21 out of 100 — Grade B, suggestion: HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics and analyst consensus. Meyka AI’s forecast model projects a monthly target of $11.79, a quarterly target of $11.01, and a 1-year target of $13.51. These model forecasts assume current macro and commodity conditions; they are model-based projections and not guarantees.
Risks and short-term opportunities ahead of earnings
Near-term upside hinges on commodity pricing and production updates; downside risk includes weaker-than-expected margins or slower precious metal sales. The company shows strong liquidity ratios (current ratio 5.08, cash per share 0.16) but negative free cash flow and net income losses show execution risk. Traders can use defined risk positions ahead of the report given elevated implied volatility and institutional ownership near 9.49%.
Final Thoughts
UAMY stock sits at $10.30 in pre-market trading ahead of earnings on Mar 19, 2026. Analysts hold a buy consensus with an average 12‑month target near $8.75 but recent broker targets range to $11.00, so views are mixed relative to current pricing. Meyka AI’s forecast model projects a 1‑year value of $13.51, implying upside of 31.14% from $10.30; the monthly projection of $11.79 implies near-term upside of 14.47%. These forecasts are model-based projections and not guarantees. For active traders, watch production, realized antimony prices and cash flow lines; for longer-term holders, the story rests on sustained commodity demand and margin recovery. Meyka AI provides this as AI-powered market analysis; use it with your own research and risk management.
FAQs
When does United States Antimony report earnings and why does it matter for UAMY stock?
UAMY reports earnings on Mar 19, 2026. The release matters because production volumes and antimony pricing drive revenue and margins, which can swing UAMY stock price quickly in the NYSE pre-market and regular session.
What is Meyka AI’s outlook and forecast for UAMY stock?
Meyka AI’s model projects a 1‑year price of $13.51 and a monthly target of $11.79. The 1‑year forecast implies about 31.14% upside from $10.30; forecasts are projections, not guarantees.
What are the biggest risks to UAMY stock after earnings?
Key risks include falling antimony prices, lower production, and continued negative free cash flow. Despite strong current liquidity ratios, earnings that miss guidance could pressure UAMY stock significantly.
How are analysts positioned on United States Antimony and UAMY stock?
Five covering analysts show a consensus Buy with an average target roughly $8.75, though recent notes raised targets to $11.00. Analyst views vary, creating near-term dispersion around UAMY stock.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)